Daaweynta UMIPIC

Daaweynta UMIPIC

Daawaynta Kaydka Siideynta Qunyar socodka ah

Jeexitaanka Ugu Yar ee Shakhsi ahaaneed ee Daawaynta Chemo-Immuno

Daawada ka hortagga kansarka oo ay samaysay isku-darka qaabaynta sii-deynta joogtada ah, dawada kiimoterabiga (laba dawooyinka), iyo adjuvant-ka difaaca ayaa si toos ah loogu duraa burada waxaana lagu dhex daraa burada iyadoo la raacayo hagida CT, ultrasound, ama endoscopy. Daawada ka hortagga kansarka ayaa si tartiib tartiib ah loo sii daayaa 7-20 maalmood gudahood, disha unugyada kansarka, ka fogaanshaha waxyeellada sunta ah ee daroogada ee jirka oo dhan iyo gaaritaanka himilada baabi'inta burada; Antigens-ka is-buro-gudka ee ay sii daayaan unugyada kansarka ee ay dilaan dawooyinka isku-dhafka ah isla mar ahaantaana, iyadoo la kaashanayo adjuvants-ka difaaca, waxay dhaqaajiyaan jawaab-celinta difaaca habaysan ee jirka, taas oo door ka qaadanaysa nadiifinta unugyada kansarka ee soo noqnoqda ama metastatic. Dilalka iyo daawaynta madax-goyneed ee tooska ah ee jireed ee bartilmaameedka ah ayaa lagu samayn karaa burooyinka halista ah iyo nabarrada dheef-shiid kiimikaadka ee qaybaha kala duwan ee jidhka, kuwaas oo ku habboon goor hore, dhexe iyo marxaladda dambe ee burooyinka adag ee dhammaan qaybaha jidhka. Daawayntani waxay ka heshay tignoolajiyada la aqoonsan yahay ee Shiinaha, Maraykanka, iyo Australia. Tan iyo markii ay codsatay 1998, waxay dawaysay in ka badan 80000 bukaan oo kansar ah waxayna ku guulaysatay natiijooyin daweyn wanaagsan!

Wax ku biirinta ugu weyni waa in daawaynta sii-daynta joogtada ahi ay midayso faa'iidooyinka kiimoterabiga iyo daweynta difaaca jirka, iyo markii ugu horreysay, labada ayaa la isku daray oo lagu dabaqay daawaynta intratumoral iyada oo la faragelinayo. Waxay isku daraysaa daaweynta maxalliga ah iyo kuwa caalamiga ah, waxayna kordhisaa diiradda iyo waqtiga ficilka daroogada iyada oo loo marayo sii-deynta joogtada ah ee daawooyinka gudaha burada, taas oo aan kaliya ka ciyaarin saameynta anticancer maxaliga ah ee daawooyinka kemotherabi, laakiin sidoo kale waxay tixgelisaa doorka immunotherapy nidaamka, sidaas darteed samaynta cilladaha daaweynta kale, bixinta fikrado cusub iyo habab loogu talagalay daaweynta kansarka, gaar ahaan loogu talagalay burooyinka dhexe iyo sare, gaar ahaan hoos u dhigista burooyinka soo noqnoqda. qiimo aad u muhiim ah; Daaweynta UMPIC waxay faa'iido u leedahay isticmaalka burada sida isha antigen-ka iyo tallaalka autologous, kaas oo sidoo kale la jaan qaadaya isbeddelka horumarinta ee Daawada Shakhsi ahaaneed. Oo lagu dabaqay rugta caafimaadka, hapten oo ay weheliso dawooyinka kiimoterabiga si loogu sii daayo sii-deynta joogtada ah ee kansarka ganaca, iyada oo la dhalinayo saameyn fog, nuxurka kaas oo ah in la keeno jawaab-celinta difaaca, T-unugyada CD4, CD8, DC, T iyo unugyada NK, iyo unugyada B-unugyada la xidhiidha buro autoantibodies: Antibodies to P53, P16, C16, C16, P16, P53, P16, P16, C, P53, P16, C, P53, C, P16, C, P53, P16, C, P16, C, P53, P16, C, P53, 16, C, P16, C, P53, P16. Survivin, p62, HCC1 iyo oncogenes kale, tani waa markii ugu horeysay ee la ogaado in T iyo B ay ku lug leeyihiin jawaab-celinta difaaca jirka, iyo hawlaha kiliinikada ee saamaynta fog iyo daaweyntan waxaa loo doortay "Hagaha Hawlgalka Kiliiniga ee Daaweynta Dhexdhexaadinta ee Kansarka Sare ee Kansarka Pancreatic" (Trial) (daabacaadda 7aad) oo ay si wadajir ah u diyaariyeen Xarunta Cilmi-baarista ee Shiinaha, Xarunta Cilmi-baarista Caafimaadka Qaranka ee Cilmi-baarista Caafimaadka Qaranka. Qaranka Isbahaysiga Innovation Innovation Interventional Medicine ayaa lagu daabacay

Journal of Clinical Radiology, mugga 43, lambarka 19, 2024, 1636-1648.

20241205094917441744

Dr.Baofa Yu iyo kooxdiisa cilmi baarista xiisaha ugu weyn waxaa ka mid ah sida soo socota:

1. Burooyinka yaryar ee fog fog waa la xakameyn karaa, oo leh caddayn iyo maqaallo;

2.Diirada-hoosaadka hoose waa la xakameyn karaa, markaa wakhtiga badbaadada bukaanku waa dheer yahay;

3.Waxay kaloo hoos u dhigtaa 80% unugyada burada wareegga wareegga (CTC), maqaal la daabacayo;

4.Waxay kicin kartaa hypothalamus ee maskaxda si ay uga qayb qaadato jawaab-celinta difaaca jirka, isla mar ahaantaana, waxay sidoo kale ilaalin kartaa xiisaha maskaxda ee muusikada si ay isugu duwo ka hortagga kansarka. Maqaalka waa la dhammaystiray, oo borofisar UCSD wuxuu soo jeedinayaa in loo gudbiyo dabeecadda ama daawada dabiiciga ah.

UMIPIC-daaweynta: Isku-darka isku-darka daroogada

Adjuvant: kordhinta falcelinta difaaca jirka iyo gaar ahaaneed
Wakiilka joogtada ah: ku haya dhammaan feejignaanta sare muddo dheer
Wakiilada antitumor: Nidaamyada FDA waxay ansixiyeen  waxay sababeen dhimashada burada si ay antigens uga sii daayaan xinjirowga.

20240824104022202220

Lix faa'iidooyin oo waaweyn oo ku-daweynta kaydka kaydka ee Qunyar-socodka ah: Beegsiga ugu yar ee weerarka, madax-goynta burooyinka, ka-hortagga difaaca, tallaallada kala duwan, waara, badbaado leh oo waxtar leh.

Faa'iidooyinka caleemaha badan ee burooyinka interception
(1) Tumoricidal  Dhexdhexaadinta goobta aasaasiga ah ee buro: iyadoo la raacayo CT ama hagida ultrasound, iyadoo ku xidhan cabbirka buro, waxaad ku duri kartaa qiyaasta ku habboon ee xal isku dhafan.
(2) Joogteynta dawada ka hortagga kansarka: xinjirtu waxay keentay xinjirowga buro si ay u hayso daawada muddo dheer oo ay gaadho waxtarka wanaagsan.
(3) Ka-hortagga difaaca jirka: Burada weyn ee ka-soo-baxa dhanka kale waxay keenaysaa fal-celinta tallaalka si loo xakameeyo lesion-ka yar ee buro ee goobta sare ee burada.
(4) Antigens-ka buro badan oo iswada leh: Antigens-ka buro-ku-xiran ayaa ah isha ka-hortagga iyo tallaalka: antigen-ka dhabta ah ee autologous, antigens-ka dhabta ah ee dhabta ah iyo antigens-ka shakhsi ahaaneed.
(5) Si fudud loo isticmaali karo: Waxay daweyn kartaa burada aasaasiga ah sidoo kale waxay daweyn kartaa burada labaad waxayna keeni kartaa daawayn shaqsiyeed.
(6) Ammaan oo waxtar leh.

Guriga
Kiisaska caadiga ah
Annaga
Nala Soo Xidhiidh

Fadlan fariin noogu dhaaf